Prediction of drug-induced kidney injury in drug discovery

References

• Adler M, Ramm S, Hafner M, Muhlich JL, Gottwald EM, Weber E, Jaklic A, Ajay AK, Svoboda D, Auerbach S. 2016. A quantitative approach to screen for nephrotoxic compounds in vitro. J Am Soc Nephrol. 27(4):1015–1028.
   PubMed Web of Science ®Google Scholar
• Arefan D, Mohamed AA, Berg WA, Zuley ML, Sumkin JH, Wu S. 2020. Deep learning modeling using normal mammograms for predicting breast cancer risk. Med Phys. 47(1):110–118.
   PubMed Web of Science ®Google Scholar
• Artunc F, Fischer I, Risler T, Erley C. 2005. Improved estimation of GFR by serum cystatin C in patients undergoing cardiac catheterization. Int J Cardiol. 102(2):173–178.
   PubMed Web of Science ®Google Scholar
• Beaufils H, Deray G, Katlama C, Dohin E, Henin D, Sazdovitch V, Jouanneau C. 1990. Foscarnet and crystals in glomerular capillary lumens. Lancet. 336(8717):755.
   PubMed Web of Science ®Google Scholar
• Ben-Israel A, Levin Y. 2006. The geometry of linear separability in data sets. Linear Algebra Appl. 416(1):75–87.
   Web of Science ®Google Scholar
• Bens M, Vandewalle A. 2008. Cell models for studying renal physiology. Pflügers Archiv-Eur J Physiol. 457(1):1–15.
   PubMed Web of Science ®Google Scholar
• Birn H, Christensen E. 2006. Renal albumin absorption in physiology and pathology. Kidney Int. 69(3):440–449.
   PubMed Web of Science ®Google Scholar
• Bonventre JV. 2009. Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant. 24(11):3265-3268
   Google Scholar
• Byrd RA, Gries CL, Buening MK. 1994. Developmental toxicology studies of vancomycin hydrochloride administered intravenously to rats and rabbits. Fundam Appl Toxicol. 23(4):590–597.
   PubMedGoogle Scholar
• Calne RY, Rolles K, Thiru S, Mcmaster P, Craddock GN, Aziz S, White DJG, Evans DB, Dunn DC, Henderson RG, et al. 1979. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet. 314(8151):1033–1036.
   Google Scholar
• Chorley BN, Ellinger-Ziegelbauer H, Tackett M, Simutis FJ, Harrill AH, McDuffie J, Atabakhsh E, Nassirpour R, Whiteley LO, Léonard J-F. 2021. Urinary miRNA biomarkers of drug-induced kidney injury and their site specificity within the nephron. Toxicol Sci. 180(1):1–16.
   PubMed Web of Science ®Google Scholar
• Choudhury D, Ahmed Z. 2006. Drug-associated renal dysfunction and injury. Nat Clin Pract Nephrol. 2(2):80–91.
   PubMedGoogle Scholar
• Christensen EI, Birn H. 2001. Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule. Am J Physiol-Renal Physiol. 280(4):F562–F573.
   PubMed Web of Science ®Google Scholar
• Chu X, Bleasby K, Evers R. 2013. Species differences in drug transporters and implications for translating preclinical findings to humans. Expert Opin Drug Metab Toxicol. 9(3):237–252.
   PubMed Web of Science ®Google Scholar
• Combes AN, Zappia L, Er PX, Oshlack A, Little MH. 2019. Single-cell analysis reveals congruence between kidney organoids and human fetal kidney. Genome Med. 11(1):1–15.
   PubMed Web of Science ®Google Scholar
• Coroneos E, Petrusevska G, Varghese F, Truong LD. 1996. Focal segmental glomerulosclerosis with acute renal failure associated with α-interferon therapy. Am J Kidney Dis. 28(6):888–892.
   PubMed Web of Science ®Google Scholar
• Daugaard G, Abildgaard U, Holstein‐Rathlou NH, Bruunshuus I, Bucher D, Leyssac PP. 1988. Renal tubular function in patients treated with high‐dose cisplatin. Clin Pharmacol Ther. 44(2):164–172.
   PubMed Web of Science ®Google Scholar
• Daugaard G, Rossing N, Rørth M. 1988. Effects of cisplatin on different measures of glomerular function in the human kidney with special emphasis on high-dose. Cancer Chemother Pharmacol. 21(2):163–167.
   PubMed Web of Science ®Google Scholar
• de Souza N. 2018. Organoids. Nat Methods. 15(1):23–23.
   Web of Science ®Google Scholar
• Delézay O, He Z, Hodin S, Saleem MA, Mismetti P, Perek N, Delavenne X. 2017. Glomerular filtration drug injury: In vitro evaluation of functional and morphological podocyte perturbations. Exp Cell Res. 361(2):300–307.
   PubMed Web of Science ®Google Scholar
• Dieterle F, Perentes E, Cordier A, Roth DR, Verdes P, Grenet O, Pantano S, Moulin P, Wahl D, Mahl A. 2010. Urinary clusterin, cystatin C, β2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat Biotechnol. 28(5):463–469.
   PubMed Web of Science ®Google Scholar
• Dresser MJ, Gray AT, Giacomini KM. 2000. Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1). J Pharmacol Exp Ther. 292(3):1146–1152.
   PubMed Web of Science ®Google Scholar
• Elberg G, Guruswamy S, Logan CJ, Chen L, Turman MA. 2008. Plasticity of epithelial cells derived from human normal and ADPKD kidneys in primary cultures. Cell Tissue Res. 331(2):495–508.
   PubMed Web of Science ®Google Scholar
• Elizondo D. 2006. The linear separability problem: some testing methods. IEEE Trans Neural Netw. 17(2):330–344.
   PubMed Web of Science ®Google Scholar
• Eti S, Cheng CY, Marshall A, Reidenberg MM. 1993. Urinary clusterin in chronic nephrotoxicity in the rat. Proc Soc Exp Biol Med. 202(4):487–490.
   PubMed Web of Science ®Google Scholar
• Gai Z, Gui T, Kullak-Ublick GA, Li Y, Visentin M. 2020. The role of mitochondria in drug-induced kidney injury. Front Physiol. 11:1079.
   PubMed Web of Science ®Google Scholar
• Gai Z, Visentin M, Hiller C, Krajnc E, Li T, Zhen J, Kullak-Ublick GA. 2016. Organic cation transporter 2 overexpression may confer an increased risk of gentamicin-induced nephrotoxicity. Antimicrob Agents Chemother. 60(9):5573–5580.
   PubMed Web of Science ®Google Scholar
• George B, Wen X, Mercke N, Gomez M, O’Bryant C, Bowles DW, Hu Y, Hogan SL, Joy MS, Aleksunes LM. 2017. Profiling of kidney injury biomarkers in patients receiving cisplatin: time‐dependent changes in the absence of clinical nephrotoxicity. Clin Pharmacol Ther. 101(4):510–518.
   PubMed Web of Science ®Google Scholar
• Ghlissi Z, Hakim A, Mnif H, Ayadi FM, Zeghal K, Rebai T, Sahnoun Z. 2013. Evaluation of colistin nephrotoxicity administered at different doses in the rat model. Renal Fail. 35(8):1130–1135.
   PubMed Web of Science ®Google Scholar
• Griffin BR, Faubel S, Edelstein CL. 2019. Biomarkers of drug-induced kidney toxicity. Ther Drug Monit. 41(2):213–226.
   PubMed Web of Science ®Google Scholar
• Gunness P, Aleksa K, Kosuge K, Ito S, Koren G. 2010. Comparison of the novel HK-2 human renal proximal tubular cell line with the standard LLC-PK1 cell line in studying drug-induced nephrotoxicity. Can J Physiol Pharmacol. 88(4):448–455.
   PubMed Web of Science ®Google Scholar
• Harpur E, Ennulat D, Hoffman D, Betton G, Gautier J-C, Riefke B, Bounous D, Schuster K, Beushausen S, Guffroy M. 2011. Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat. Toxicol Sci. 122(2):235–252.
   PubMed Web of Science ®Google Scholar
• Herlitz LC, D’Agati VD, Markowitz GS. 2012. Crystalline nephropathies. Arch Pathol Lab Med. 136(7):713–720.
   PubMed Web of Science ®Google Scholar
• Ho ES, Lin DC, Mendel DB, Cihlar T. 2000. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J Am Soc Nephrol. 11(3):383–393.
   PubMed Web of Science ®Google Scholar
• Homan KA, Kolesky DB, Skylar-Scott MA, Herrmann J, Obuobi H, Moisan A, Lewis JA. 2016. Bioprinting of 3D convoluted renal proximal tubules on perfusable chips. Sci Rep. 6(1):1–13.
   PubMed Web of Science ®Google Scholar
• Homan WP, Fabre JW, Williams KA, Millard PR, Morris PJ. 1980. Studies on the immunosuppressive properties of cyclosporin A in rats receiving renal allografts. Transplantation. 29(5):361–366.
   PubMed Web of Science ®Google Scholar
• Homan WP, French ME, Millard P, Denton TG, Fabre JW, Morris PJ. 1980. Studies on the effects of cyclosporin A upon renal allograft rejection in the dog. Surgery. 88(1):168–173.
   PubMed Web of Science ®Google Scholar
• Hsueh CH, Hsu V, Zhao P, Zhang L, Giacomini K, Huang SM. 2018. PBPK modeling of the effect of reduced kidney function on the pharmacokinetics of drugs excreted renally by organic anion transporters. Clin Pharmacol Ther. 103(3):485–492.
   PubMed Web of Science ®Google Scholar
• Jang K-J, Mehr AP, Hamilton GA, McPartlin LA, Chung S, Suh K-Y, Ingber DE. 2013. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. Integr Biol. 5(9):1119–1129.
   Google Scholar
• Jansen J, De Napoli I, Fedecostante M, Schophuizen C, Chevtchik N, Wilmer M, Van Asbeck A, Croes H, Pertijs J, Wetzels J. 2015. Human proximal tubule epithelial cells cultured on hollow fibers: living membranes that actively transport organic cations. Sci Rep. 5(1):1–12.
   Web of Science ®Google Scholar
• Jensen D, Kierulf-Lassen C, Kristensen MLV, Nørregaard R, Weyer K, Nielsen R, Christensen EI, Birn H. 2017. Megalin dependent urinary cystatin C excretion in ischemic kidney injury in rats. PloS One. 12(6):e0178796.
   PubMed Web of Science ®Google Scholar
• Kandasamy K, Chuah JKC, Su R, Huang P, Eng KG, Xiong S, Li Y, Chia CS, Loo L-H, Zink D. 2015. Prediction of drug-induced nephrotoxicity and injury mechanisms with human induced pluripotent stem cell-derived cells and machine learning methods. Sci Rep. 5:12337.
   PubMed Web of Science ®Google Scholar
• Kriegel AJ, Liang M. 2013. MicroRNA in situ hybridization for formalin fixed kidney tissues. JoVE. (81):50785.
   Google Scholar
• Kumar SV, Er PX, Lawlor KT, Motazedian A, Scurr M, Ghobrial I, Combes AN, Zappia L, Oshlack A, Stanley EG, et al. 2019. Kidney micro-organoids in suspension culture as a scalable source of human pluripotent stem cell-derived kidney cells. Development. 146(5):dev172361.
   PubMed Web of Science ®Google Scholar
• Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Saito Y, Yoshioka T, Ogawa Y, Imamaki H, Kusakabe T. 2009. Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int. 75(3):285–294.
   PubMed Web of Science ®Google Scholar
• Lechner J, Pfaller W. 2001. Interferon α2b increases paracellular permeability of renal proximal tubular LLC-PK1 cells via a mitogen activated protein kinase signaling pathway. Renal Fail. 23(3–4):573–588.
   PubMed Web of Science ®Google Scholar
• Levering KR, Conaway N, Kurtz KJ. 2020. Revisiting the linear separability constraint: new implications for theories of human category learning. Mem Cogn. 48(3):313–335.
   Web of Science ®Google Scholar
• Li Y, Kandasamy K, Chuah JKC, Lam YN, Toh WS, Oo ZY, Zink D. 2014. Identification of nephrotoxic compounds with embryonic stem-cell-derived human renal proximal tubular-like cells. Mol Pharmaceutics. 11(7):1982–1990.
   PubMed Web of Science ®Google Scholar
• Li Y, Oo ZY, Chang SY, Huang P, Eng KG, Zeng JL, Kaestli AJ, Gopalan B, Kandasamy K, Tasnim F, et al. 2013. An in vitro method for the prediction of renal proximal tubular toxicity in humans. Toxicol Res. 2(5):352–365.
   Web of Science ®Google Scholar
• Li Z, Litchfield J, Tess DA, Carlo AA, Eng H, Keefer C, Maurer TS. 2020. A physiologically based in silico tool to assess the risk of drug-related crystalluria. J Med Chem. 63(12):6489–6498.
   PubMed Web of Science ®Google Scholar
• Luo Q-H, Chen M-L, Chen Z-L, Huang C, Cheng A-C, Fang J, Tang L, Geng Y. 2016. Evaluation of KIM-1 and NGAL as early indicators for assessment of gentamycin-induced nephrotoxicity in vivo and in vitro. Kidney Blood Press Res. 41(6):911–918.
   PubMed Web of Science ®Google Scholar
• Magee TV, Brown MF, Starr JT, Ackley DC, Abramite JA, Aubrecht J, Butler A, Crandon JL, Dib-Hajj F, Flanagan ME. 2013. Discovery of Dap-3 polymyxin analogues for the treatment of multidrug-resistant gram-negative nosocomial infections. J Med Chem. 56(12):5079–5093.
   PubMed Web of Science ®Google Scholar
• Mall C, Rocke DM, Durbin-Johnson B, Weiss RH. 2013. Stability of miRNA in human urine supports its biomarker potential. Biomarkers Med. 7(4):623–631.
   PubMed Web of Science ®Google Scholar
• Marshall C, Pippin J, Krofft R, Shankland S. 2006. Puromycin aminonucleoside induces oxidant-dependent DNA damage in podocytes in vitro and in vivo. Kidney Int. 70(11):1962–1973.
   PubMed Web of Science ®Google Scholar
• Min S-Y, Ha D-S, Ha T-S. 2018. Puromycin aminonucleoside triggers apoptosis in podocytes by inducing endoplasmic reticulum stress. Kidney Res Clin Prac. 37(3):210.
   PubMed Web of Science ®Google Scholar
• Mody H, Vaidya T, Lesko L, Ait‐Oudhia S. 2019. In vitro evaluation of cimetidine reno‐protective effects on cisplatin‐induced kidney injury. FASEB J. 33(S1):671.674–671.674.
   Google Scholar
• Mori K, Saito R, Nakamaru Y, Shimizu M, Yamazaki H. 2016. Physiologically based pharmacokinetic–pharmacodynamic modeling to predict concentrations and actions of sodium‐dependent glucose transporter 2 inhibitor canagliflozin in human intestines and renal tubules. Biopharm Drug Dispos. 37(8):491–506.
   PubMed Web of Science ®Google Scholar
• Morizane R, Lam AQ, Freedman BS, Kishi S, Valerius MT, Bonventre JV. 2015. Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat Biotechnol. 33(11):1193–1200.
   PubMed Web of Science ®Google Scholar
• Murty M, Sharma U, Pandey V, Kankare S. 2013. Serum cystatin C as a marker of renal function in detection of early acute kidney injury. Indian J Nephrol. 23(3):180.
   PubMedGoogle Scholar
• Narayanan K, Schumacher KM, Tasnim F, Kandasamy K, Schumacher A, Ni M, Gao S, Gopalan B, Zink D, Ying JY. 2013. Human embryonic stem cells differentiate into functional renal proximal tubular–like cells. Kidney Int. 83(4):593–603.
   PubMed Web of Science ®Google Scholar
• O’Donnell JN, Rhodes NJ, Lodise TP, Prozialeck WC, Miglis CM, Joshi MD, Venkatesan N, Pais G, Cluff C, Lamar PC, et al. 2017. 24-Hour pharmacokinetic relationships for vancomycin and novel urinary biomarkers of acute kidney injury. Antimicrob Agents Chemother. 61(11):e00416–e00417.
   PubMed Web of Science ®Google Scholar
• Pais GM, Liu J, Zepcan S, Avedissian SN, Rhodes NJ, Downes KJ, Moorthy GS, Scheetz MH. 2020. Vancomycin‐induced kidney injury: animal models of toxicodynamics, mechanisms of injury, human translation, and potential strategies for prevention. Pharmacotherapy. 40(5):438–454.
   PubMed Web of Science ®Google Scholar
• Pavkovic M, Robinson-Cohen C, Chua AS, Nicoara O, Cárdenas-González M, Bijol V, Ramachandran K, Hampson L, Pirmohamed M, Antoine DJ, et al. 2016. Detection of drug-induced acute kidney injury in humans using urinary KIM-1, miR-21,-200c, and-423. Toxicol Sci. 152(1):205–213.
   PubMed Web of Science ®Google Scholar
• Petrosyan A, Cravedi P, Villani V, Angeletti A, Manrique J, Renieri A, De Filippo RE, Perin L, Da Sacco S. 2019. A glomerulus-on-a-chip to recapitulate the human glomerular filtration barrier. Nat Commun. 10(1):1–17.
   PubMed Web of Science ®Google Scholar
• Pianta TJ, Pickering JW, Succar L, Chin M, Davidson T, Buckley NA, Mohamed F, Endre ZH. 2017. Dexamethasone modifies cystatin c-based diagnosis of acute kidney injury during cisplatin-based chemotherapy. Kidney Blood Press Res. 42(1):62–75.
   PubMed Web of Science ®Google Scholar
• Price SA, Davies D, Rowlinson R, Copley CG, Roche A, Falkenberg FW, Riccardi D, Betton GR. 2010. Characterization of renal papillary antigen 1 (RPA-1), a biomarker of renal papillary necrosis. Toxicol Pathol. 38(3):346–358.
   PubMed Web of Science ®Google Scholar
• Qu C, Gao L, Yu X-Q, Wei M, Fang G-Q, He J, Cao L-X, Ke L, Tong Z-H, Li W-Q. 2020. Machine learning models of acute kidney injury prediction in acute pancreatitis patients. Gastroenterol Res Pract. 2020:3431290.
   PubMed Web of Science ®Google Scholar
• Raies AB, Bajic VB. 2016. In silico toxicology: computational methods for the prediction of chemical toxicity. Wiley Interdiscip Rev Comput Mol Sci. 6(2):147–172.
   PubMed Web of Science ®Google Scholar
• Ramesh G, Reeves WB. 2002. TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest. 110(6):835–842.
   PubMed Web of Science ®Google Scholar
• Ramm S, Adler M, Vaidya VS. 2016. A high‐throughput screening assay to identify kidney toxic compounds. Curr Protocols Toxicol. 69(1):9.10.11–19.10.26.
   Google Scholar
• Randjelovic P, Veljkovic S, Stojiljkovic N, Sokolovic D, Ilic I. 2017. Gentamicin nephrotoxicity in animals: current knowledge and future perspectives. EXCLI Journal. 16:388.
   PubMed Web of Science ®Google Scholar
• Redfern W, Ewart L, Hammond T, Bialecki R, Kinter L, Lindgren S, Pollard C, Roberts R, Rolf M, Valentin J. 2010. Impact and frequency of different toxicities throughout the pharmaceutical life cycle. Toxicol. 114(S1):1081.
   Google Scholar
• Rosenberg ME, Silkensen J. 1995. Clusterin: physiologic and pathophysiologic considerations. Int J Biochem Cell Biol. 27(7):633–645.
   PubMed Web of Science ®Google Scholar
• Sansanwal P, Li L, Sarwal MM. 2015. Inhibition of intracellular clusterin attenuates cell death in nephropathic cystinosis. J Am Soc Nephrol. 26(3):612–625.
   PubMed Web of Science ®Google Scholar
• Sato T, Ishikawa A, Homma Y. 2013. Effect of reduced form of coenzyme Q10 on cyclosporine nephrotoxicity. Exp Clin Transplant. 11(1):17–20.
   PubMed Web of Science ®Google Scholar
• Sayama H, Takubo H, Komura H, Kogayu M, Iwaki M. 2014. Application of a physiologically based pharmacokinetic model informed by a top-down approach for the prediction of pharmacokinetics in chronic kidney disease patients. AAPS J. 16(5):1018–1028.
   PubMed Web of Science ®Google Scholar
• Shaw M. 2005. The use of histologically defined specific biomarkers in drug development with special reference to the glutathione S-transferases. Cancer Biomarkers. 1(1):69–74.
   PubMedGoogle Scholar
• Shinke H, Masuda S, Togashi Y, Ikemi Y, Ozawa A, Sato T, Kim YH, Mishima M, Ichimura T, Bonventre JV. 2015. Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients. Cancer Chemother Pharmacol. 76(5):989–996.
   PubMed Web of Science ®Google Scholar
• Simon N, Morin C, Urien S, Tillement JP, Bruguerolle B. 2003. Tacrolimus and sirolimus decrease oxidative phosphorylation of isolated rat kidney mitochondria. Br J Pharmacol. 138(2):369–376.
   PubMed Web of Science ®Google Scholar
• Sohn S-J, Kim SY, Kim HS, Chun Y-J, Han SY, Kim SH, Moon A. 2013. In vitro evaluation of biomarkers for cisplatin-induced nephrotoxicity using HK-2 human kidney epithelial cells. Toxicol Lett. 217(3):235–242.
   PubMed Web of Science ®Google Scholar
• Soo JY-C, Jansen J, Masereeuw R, Little MH. 2018. Advances in predictive in vitro models of drug-induced nephrotoxicity. Nat Rev Nephrol. 14(6):378–393.
   PubMed Web of Science ®Google Scholar
• Su R, Li Y, Zink D, Loo L-H. 2014. Supervised prediction of drug-induced nephrotoxicity based on interleukin-6 and-8 expression levels. BMC Bioinf. 15(Suppl 16):S16. (
   PubMed Web of Science ®Google Scholar
• Takasato M, Er P, Becroft M, Vanslambrouck JM, Stanley E, Elefanty AG, Little MH. 2014. Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney. Nat Cell Biol. 16(1):118–126.
   PubMed Web of Science ®Google Scholar
• Takasato M, Er PX, Chiu HS, Maier B, Baillie GJ, Ferguson C, Parton RG, Wolvetang EJ, Roost MS, Chuva de Sousa Lopes SM, et al. 2015. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature. 526(7574):564–568.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Slitt AL, Leazer TM, Maher JM, Klaassen CD. 2004. Tissue distribution and hormonal regulation of the breast cancer resistance protein (Bcrp/Abcg2) in rats and mice. Biochem Biophys Res Commun. 326(1):181–187.
   Web of Science ®Google Scholar
• Vaidya VS, Ozer JS, Dieterle F, Collings FB, Ramirez V, Troth S, Muniappa N, Thudium D, Gerhold D, Holder DJ. 2010. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol. 28(5):478–485.
   PubMed Web of Science ®Google Scholar
• Vamathevan J, Clark D, Czodrowski P, Dunham I, Ferran E, Lee G, Li B, Madabhushi A, Shah P, Spitzer M. 2019. Applications of machine learning in drug discovery and development. Nat Rev Drug Discov. 18(6):463–477.
   PubMed Web of Science ®Google Scholar
• Van Biesen W, Vanholder R, Lameire N. 2006. Defining acute renal failure: RIFLE and beyond. Clin J Am Soc Nephrol. 1(6):1314–1319.
   PubMed Web of Science ®Google Scholar
• Waikar SS, Bonventre JV. 2006. Can we rely on blood urea nitrogen as a biomarker to determine when to initiate dialysis? Clin J Am Soc Nephrol. 1:903–904.
   PubMed Web of Science ®Google Scholar
• Wang E-J, Snyder RD, Fielden MR, Smith RJ, Gu Y-Z. 2008. Validation of putative genomic biomarkers of nephrotoxicity in rats. Toxicology. 246(2–3):91–100.
   PubMed Web of Science ®Google Scholar
• Westhuyzen J, Endre ZH, Reece G, Reith DM, Saltissi D, Morgan TJ. 2003. Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transpl. 18(3):543–551.
   PubMed Web of Science ®Google Scholar
• Wibell L. 1978. The serum level and urinary excretion of beta2-microglobulin in health and renal disease. Pathol-Biol. 26(6):295–301.
   PubMed Web of Science ®Google Scholar
• Wold JS, Turnipseed SA. 1981. Toxicology of vancomycin in laboratory animals. Rev Infect Dis. 3(Supplement_2):S224–S229.
   PubMedGoogle Scholar
• Yano R, Ohtsu F, Goto N. 2015. Physicochemical properties of causative drugs associated with renal nephrotoxicity. J Pharmacovigil. 03(06):2.
   Google Scholar
• Yeung CK, Himmelfarb J. 2019. Kidneys on chips: emerging technology for preclinical drug development. Clin J Am Soc Nephrol. 14(1):144–146.
   PubMed Web of Science ®Google Scholar
• Yin L, Du G, Zhang B, Zhang H, Yin R, Zhang W, Yang S-M. 2020. Efficient drug screening and nephrotoxicity assessment on co-culture microfluidic kidney chip. Sci Rep. 10(1):1–11.
   PubMed Web of Science ®Google Scholar
• Yin L, Zhang H, Yang S-M, Zhang W. 2019. A three-layer microfluidic kidney chip for drug nephrotoxicity test. IJBBB. 9:237–247.
   Google Scholar
• Zamek‐Gliszczynski MJ, Taub ME, Chothe PP, Chu X, Giacomini KM, Kim RB, Ray AS, Stocker SL, Unadkat JD, Wittwer MB. 2018. Transporters in drug development: 2018 ITC recommendations for transporters of emerging clinical importance. Clin Pharmacol Ther. 104(5):890–899.
   PubMed Web of Science ®Google Scholar
• Zou L, Stecula A, Gupta A, Prasad B, Chien H-C, Yee SW, Wang L, Unadkat JD, Stahl SH, Fenner KS. 2018. Molecular mechanisms for species differences in organic anion transporter 1, OAT1: implications for renal drug toxicity. Mol Pharmacol. 94(1):689–699.
   PubMed Web of Science ®Google Scholar